Antiarrhythmic Drugs

Mechanisms of Antiarrhythmic and Proarrhythmic Actions

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Antiarrhythmic Drugs by W. Haverkamp, G. Hindricks, Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: W. Haverkamp, G. Hindricks ISBN: 9783642856242
Publisher: Springer Berlin Heidelberg Publication: December 6, 2012
Imprint: Springer Language: English
Author: W. Haverkamp, G. Hindricks
ISBN: 9783642856242
Publisher: Springer Berlin Heidelberg
Publication: December 6, 2012
Imprint: Springer
Language: English

The past 10 years have seen a remarkable change in the approach to cardiac arrhythmias, from a position of confidence and a feeling of well-being about pharmacological treatment to a situation in which there is now marked uncertainty and general apprehension about the role of antiarrhythmic drugs. Until relatively recently the prevailing concept in antiarrhythmic therapy was that arrhythmias could be controlled by drugs which slowed conduction or suppressed automaticity, goals well served by the sodium channel-blocking drugs and glycosides. Drug re­ search was based largely on the development of agents mimicking those already available, but with greater efficacy, fewer side effects or a more favourable phar­ macokinetic profile. The CAST trial stands out as a landmark in the evolution of arrhytmia manage­ ment; rarely has a single trial had such a profound impact not only on clinical prac­ tice, but also on the whole approach of those involved in the research, development and regulation of antiarrhythmic drugs. The results of the CAST trial, designed to redress the shortcomings of earlier trials which had failed to demonstrate the anticipated improvement in mortality post-myocardial infarction with the use of class I agents, are well known. The CAST and CAST II showed an increase in mor­ tality associated with the active agent (encainide, flecainide or morizicine) com­ pared to placebo treatment. They firmly established the potential danger in the use of class I drugs.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The past 10 years have seen a remarkable change in the approach to cardiac arrhythmias, from a position of confidence and a feeling of well-being about pharmacological treatment to a situation in which there is now marked uncertainty and general apprehension about the role of antiarrhythmic drugs. Until relatively recently the prevailing concept in antiarrhythmic therapy was that arrhythmias could be controlled by drugs which slowed conduction or suppressed automaticity, goals well served by the sodium channel-blocking drugs and glycosides. Drug re­ search was based largely on the development of agents mimicking those already available, but with greater efficacy, fewer side effects or a more favourable phar­ macokinetic profile. The CAST trial stands out as a landmark in the evolution of arrhytmia manage­ ment; rarely has a single trial had such a profound impact not only on clinical prac­ tice, but also on the whole approach of those involved in the research, development and regulation of antiarrhythmic drugs. The results of the CAST trial, designed to redress the shortcomings of earlier trials which had failed to demonstrate the anticipated improvement in mortality post-myocardial infarction with the use of class I agents, are well known. The CAST and CAST II showed an increase in mor­ tality associated with the active agent (encainide, flecainide or morizicine) com­ pared to placebo treatment. They firmly established the potential danger in the use of class I drugs.

More books from Springer Berlin Heidelberg

Cover of the book Exhibit Marketing and Trade Show Intelligence by W. Haverkamp, G. Hindricks
Cover of the book Philipp Franz von Siebold and His Era by W. Haverkamp, G. Hindricks
Cover of the book Linear Isentropic Oscillations of Stars by W. Haverkamp, G. Hindricks
Cover of the book Recent Advances in Laser Ablation ICP-MS for Archaeology by W. Haverkamp, G. Hindricks
Cover of the book Strafrechtliche Sanktionen by W. Haverkamp, G. Hindricks
Cover of the book Sport in der Schwangerschaft by W. Haverkamp, G. Hindricks
Cover of the book Applied Conjoint Analysis by W. Haverkamp, G. Hindricks
Cover of the book Ephemeridenrechnung Schritt für Schritt by W. Haverkamp, G. Hindricks
Cover of the book Entscheidungstheorie und –praxis by W. Haverkamp, G. Hindricks
Cover of the book Change Management by W. Haverkamp, G. Hindricks
Cover of the book Forschungsmethoden und Evaluation in den Sozial- und Humanwissenschaften by W. Haverkamp, G. Hindricks
Cover of the book Design, Synthesis, and Structure-Property Relationship Study of Polymer Field-Effect Transistors by W. Haverkamp, G. Hindricks
Cover of the book JIMD Reports, Volume 15 by W. Haverkamp, G. Hindricks
Cover of the book Materials with Complex Behaviour by W. Haverkamp, G. Hindricks
Cover of the book Biomedical Optical Imaging Technologies by W. Haverkamp, G. Hindricks
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy